Relationship between inhibition of renal Na+ plus K+-ATPase and natriuresis.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D003404:Creatinine / Q000652:urine; D004077:Digoxin / Q000494:pharmacology; D004285:Dogs; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000378:metabolism*; D007672:Kidney Cortex / Q000201:enzymology; D007679:Kidney Medulla / Q000201:enzymology; D007700:Kinetics; D008628:Mercury / Q000494:pharmacology; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology; D009318:Natriuresis; D009941:Organomercury Compounds / Q000494:pharmacology; D009942:Organometallic Compounds / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D012039:Regional Blood Flow; D012964:Sodium / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D013045:Species Specificity; D013997:Time Factors; D014667:Vasopressins / Q000494:pharmacology
D009941:Organomercury Compounds; D009942:Organometallic Compounds; D014667:Vasopressins; D010042:Ouabain; D004077:Digoxin; D012964:Sodium; D003404:Creatinine; D000251:Adenosine Triphosphatases; D008628:Mercury; D011188:Potassium